| 000 | 01157 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514035356.0 | ||
| 264 | 0 | _c20020812 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a1368-504X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClayton, Peter E | |
| 245 | 0 | 0 |
_aIs final height the only target of paediatric human growth hormone treatment? _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice. Supplement _cMay 2002 |
||
| 300 |
_a3-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 |
_aBody Height _xdrug effects |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xdeficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aQuality of Life |
| 773 | 0 |
_tInternational journal of clinical practice. Supplement _gno. 126 _gp. 3-7 |
|
| 999 |
_c11984932 _d11984932 |
||